Novorapid Flexpen 100 Iu Inj 3 Ml Pen

NOVORAPID FLEXPEN 100 IU INJ 3 ML PEN

NovoRapid FlexPen is a rapid-acting insulin analogue used for the management of diabetes mellitus. It comes in a pre-filled pen designed for ease of use.

Name

• Brand Name: NovoRapid FlexPen
• Common Name: Insulin Aspart

Composition

Each milliliter of the solution contains 100 units of insulin aspart. Each 3 ml pre-filled pen delivers a total of 300 units of insulin aspart. Inactive ingredients include glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide, and water for injections.

Uses

NovoRapid FlexPen is prescribed for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. It works by helping to lower high blood sugar levels, thereby preventing complications associated with diabetes.

Dosage and Administration

NovoRapid FlexPen is administered as a subcutaneous injection into the abdomen, thighs, buttocks, or upper arms. It is crucial to rotate injection sites regularly within the same region to reduce the risk of skin changes. Due to its rapid onset of action, it should generally be injected immediately before a meal, or, if necessary, soon after starting a meal, to minimize the risk of low blood sugar. The dosage is individualized by a physician, with typical daily requirements ranging between 0.5 and 1.0 Units/kg/day for adults and children. NovoRapid is often used in combination with intermediate-acting or long-acting insulin preparations. The FlexPen is a dial-a-dose device, capable of delivering 1 to 60 units in single-unit increments.

Side Effects

• Common Side Effects: The most common side effect is low blood sugar levels (hypoglycaemia), which can manifest as cold sweats, pale skin, headache, rapid heartbeat, hunger, nausea, temporary visual disturbances, drowsiness, unusual tiredness, weakness, nervousness, tremor, anxiety, and confusion.
• Injection Site Reactions: Local reactions such as pain, redness, hives, bruising, swelling, or itching may occur at the injection site, usually resolving within a few weeks. Other skin changes like lipodystrophy (depression or thickening of the skin) or cutaneous amyloidosis (lumps under the skin) can also occur.
• Serious Side Effects: Severe hypoglycaemia can lead to disorientation, seizures, loss of consciousness, and potentially brain damage or death if left untreated. In very rare cases, systemic allergic reactions can be life-threatening.

Precautions

Do not use NovoRapid FlexPen if you are allergic to insulin aspart or any of its ingredients, or if you are currently experiencing low blood sugar. It is essential to use a new needle for each injection and never share needles or pens. Alcohol consumption can significantly impact blood sugar levels and alter insulin requirements. Patients with kidney or liver disease, as well as elderly individuals, should use this medicine with caution, requiring more frequent blood sugar monitoring and potential dose adjustments.

Various medications can interact with NovoRapid, potentially causing blood sugar levels to fall (e.g., other antidiabetic drugs, MAOIs, beta-blockers, ACE inhibitors, salicylates, anabolic steroids, sulfonamides) or rise (e.g., oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, danazol). Individuals with visual impairment should seek assistance when using the pen. While generally safe during pregnancy and breastfeeding, careful monitoring and dose adjustments may be necessary during pregnancy. Patients should exercise caution when driving or operating machinery, as fluctuating blood sugar levels can impair concentration and reaction time.

Storage

Unopened NovoRapid FlexPen should be stored in a refrigerator (2°C to 8°C) and must not be frozen. Once in use, or when carried as a spare, the pen can be stored below 30°C or in a refrigerator (2°C to 8°C) for a maximum of 4 weeks. After 4 weeks, the pen should be discarded, even if some medicine remains. It is vital to protect the pen from excessive heat and light by keeping the pen cap on when not in use. Do not use the medicine if the solution is not clear and colorless, or if it has been frozen. Keep out of the reach of children.

What is Novorapid FlexPen 100 IU used for?

Novorapid FlexPen 100 IU is a rapid-acting insulin analogue used to treat diabetes mellitus (both Type 1 and Type 2) in adults, adolescents, and children aged 1 year and above. It helps to control blood sugar levels, especially after meals, and reduces the risk of long-term diabetes complications.

How does Novorapid FlexPen 100 IU work?

Novorapid contains insulin aspart, which is a modern, rapid-acting insulin. It works by facilitating the uptake of glucose from the blood into muscle and fat cells and simultaneously inhibiting the liver's production of glucose. After subcutaneous injection, it starts to lower blood sugar within 10 to 20 minutes, reaches its maximum effect between 1 and 3 hours, and its effect can last for up to 5 hours.

What is the usual dosage for Novorapid FlexPen 100 IU?

The dosage of Novorapid FlexPen is individualized and determined by a physician based on the patient's specific needs. Typically, the daily insulin requirement in adults and children ranges between 0.5 and 1.0 Units/kg/day. It is generally used in combination with intermediate-acting or long-acting insulin and should be injected immediately before a meal or, if necessary, soon after the start of a meal.

What are the possible side effects of Novorapid FlexPen 100 IU?

The most common side effect is hypoglycemia (low blood sugar), which can occur if the insulin dose is too high relative to requirements, or if meals are missed or delayed. Other potential side effects include injection site reactions like pain, redness, hives, bruising, swelling, or itching. These usually resolve within a few weeks. Less common effects include lipodystrophy (depression or thickening of the skin) or lumps under the skin (cutaneous amyloidosis) at the injection site. Serious allergic reactions are very rare but can be life-threatening.

Is Novorapid FlexPen 100 IU safe during pregnancy or breastfeeding?

Novorapid can generally be used during pregnancy, but managing diabetes can be more challenging. Insulin needs may decrease in the first trimester and increase in the last six months. It is important to have careful blood glucose control and monitoring. There are no restrictions on using Novorapid during breastfeeding, and it poses no risk to the baby. However, the dosage may need adjustment.

Can Novorapid FlexPen 100 IU be taken with other medications?

Many medicines can affect glucose metabolism and interact with Novorapid, potentially requiring changes in your insulin dose. Some medications, like other antidiabetic drugs, MAOIs, beta-blockers, ACE inhibitors, salicylates, anabolic steroids, and sulfonamides, may reduce insulin requirements. Conversely, substances like oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, and danazol may increase insulin requirements. Alcohol can also intensify or reduce the hypoglycaemic effect of insulin. Always inform your doctor or pharmacist about all medicines, vitamins, and supplements you are taking.

What precautions should be taken while using Novorapid FlexPen 100 IU?

Always monitor your blood sugar levels regularly. Carry sugary food or juice to treat mild to moderate hypoglycemia immediately. Rotate injection sites within the same region to prevent skin changes like lipodystrophy. Inform your doctor if you have kidney or liver problems, or issues with your adrenal, pituitary, or thyroid glands, as these can affect insulin needs. Exercise and diet changes can also impact insulin requirements, so discuss these with your doctor. Do not share your FlexPen with others.

What happens if a dose of Novorapid FlexPen 100 IU is missed?

If you forget your insulin dose, test your blood sugar level as soon as possible. If you are unsure what to do, contact your doctor, diabetes education nurse, or pharmacist. Do not use a double dose to make up for a missed one. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. If you remember soon after the missed dose, take it with some carbohydrates within 10 minutes of the injection.

How should Novorapid FlexPen 100 IU be stored?

Unused Novorapid FlexPens should be stored in a refrigerator at 2°C to 8°C and must not be frozen. Once a pen is in use or carried as a spare, it can be kept at temperatures below 30°C or in a refrigerator (2°C to 8°C) for a maximum of 4 weeks. Protect the pen from excessive heat and light by keeping the pen cap on when not in use. Discard the in-use pen after 4 weeks, even if there is still insulin remaining.